17th Drug Discovery Innovation Programme

Event date

Wednesday, 5 Oct — Thursday, 6 Oct '22

Domainex will be attending this 2-day event including top-level strategic content, current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.

The 17th Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to combat these.

News

Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services

4 Nov '24

Press Release

Domainex included in inaugural special report from the Financial Times recognising Europe’s Long-Term Growth Champions

30 Oct '24

Press Release

Synthesis in Review: Boryl Radical Mediated Halogen Atom Transfer for Versatile C-C Bond Formation and Stereospecific Alkenylidene Homologation of Organoboronates

15 Oct '24

Blog Post

17th Drug Discovery Innovation Programme

News

Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services

Domainex included in inaugural special report from the Financial Times recognising Europe’s Long-Term Growth Champions

Synthesis in Review: Boryl Radical Mediated Halogen Atom Transfer for Versatile C-C Bond Formation and Stereospecific Alkenylidene Homologation of Organoboronates

Upcoming Events

Dec 4 Genesis 2024

Dec 9 Webinar | The reemergence of covalent compounds: Domainex’s approach to covalent fragment screening

Offerings

Research Phases

Therapeutic Areas

Target Classes

Approaches & Techniques